AIP
CKPT

Ameritas Investment Partners’s Checkpoint Therapeutics CKPT Stock Holding History

Ameritas Investment Partners’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-437
Closed -$14K – 3088
2021
Q1 		$14K Buy
437
+234
+115% +$7.84K ﹤0.01% 2708
2020
Q4 		$5K Hold
203
– – ﹤0.01% 2968
2020
Q3 		$5K Hold
203
– – ﹤0.01% 2967
2020
Q2 		$4K Hold
203
– – ﹤0.01% 2984
2020
Q1 		$3K Hold
203
– – ﹤0.01% 2905
2019
Q4 		$3K Hold
203
– – ﹤0.01% 2943
2019
Q3 		$5K Hold
203
– – ﹤0.01% 2926
2019
Q2 		$6K Buy
+203
New +$7.97K ﹤0.01% 2915

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Ameritas Investment Partners's CKPT Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Checkpoint Therapeutics (CKPT) in Q2 2021, closing a stake of 437 shares — an estimated $14K sold.

Ameritas Investment Partners first reported a position in CKPT in Q2 2019 and held it in 8 quarters. The position peaked at $14K in Q1 2021. 69 funds tracked by Wall St. Rank hold CKPT as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Checkpoint Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 437 Checkpoint Therapeutics shares in Q2 2021, an estimated $14K.
  • Ameritas Investment Partners first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 8 quarters.
  • Ameritas Investment Partners's Checkpoint Therapeutics position peaked at $14K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.